MedKoo Cat#: 561771 | Name: BRD9876
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BRD9876 is a selective inhibitor of MM1S growth. It is selective for microtubule bound Eg5 and causes a rapid arrest in G2/M phase.

Chemical Structure

BRD9876
BRD9876
CAS#32703-82-5

Theoretical Analysis

MedKoo Cat#: 561771

Name: BRD9876

CAS#: 32703-82-5

Chemical Formula: C16H14N2

Exact Mass: 234.1157

Molecular Weight: 234.30

Elemental Analysis: C, 82.02; H, 6.02; N, 11.96

Price and Availability

Size Price Availability Quantity
250mg USD 250.00 2 Weeks
1g USD 350.00 2 Weeks
5g USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
BRD9876; BRD-9876; BRD 9876;
IUPAC/Chemical Name
6-(tert-Butyl)naphthalene-2,3-dicarbonitrile
InChi Key
MKILROQBJOOZKC-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H14N2/c1-16(2,3)15-5-4-11-6-13(9-17)14(10-18)7-12(11)8-15/h4-8H,1-3H3
SMILES Code
N#CC1=C(C#N)C=C2C=C(C(C)(C)C)C=CC2=C1
Appearance
Solid powder
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 234.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Chen GY, Kang YJ, Gayek AS, Youyen W, Tüzel E, Ohi R, Hancock WO. Eg5 Inhibitors Have Contrasting Effects on Microtubule Stability and Metaphase Spindle Integrity. ACS Chem Biol. 2017 Apr 21;12(4):1038-1046. doi: 10.1021/acschembio.6b01040. Epub 2017 Feb 22. PubMed PMID: 28165699; PubMed Central PMCID: PMC5515541. 2: Chattopadhyay S, Stewart AL, Mukherjee S, Huang C, Hartwell KA, Miller PG, Subramanian R, Carmody LC, Yusuf RZ, Sykes DB, Paulk J, Vetere A, Vallet S, Santo L, Cirstea DD, Hideshima T, Dančík V, Majireck MM, Hussain MM, Singh S, Quiroz R, Iaconelli J, Karmacharya R, Tolliday NJ, Clemons PA, Moore MA, Stern AM, Shamji AF, Ebert BL, Golub TR, Raje NS, Scadden DT, Schreiber SL. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. Cell Rep. 2015 Feb 4. pii: S2211-1247(15)00030-3. doi: 10.1016/j.celrep.2015.01.017. [Epub ahead of print] PubMed PMID: 25660025; PubMed Central PMCID: PMC4524791.